FR2640638B1
(fr)
|
1988-12-20 |
1991-02-15 |
Commissariat Energie Atomique |
Bioreacteur et dispositif pour la culture de cellules animales
|
US6204059B1
(en)
|
1994-06-30 |
2001-03-20 |
University Of Pittsburgh |
AAV capsid vehicles for molecular transfer
|
US5625048A
(en)
|
1994-11-10 |
1997-04-29 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
US6924128B2
(en)
|
1994-12-06 |
2005-08-02 |
Targeted Genetics Corporation |
Packaging cell lines for generation of high titers of recombinant AAV vectors
|
US5741657A
(en)
|
1995-03-20 |
1998-04-21 |
The Regents Of The University Of California |
Fluorogenic substrates for β-lactamase and methods of use
|
US5756283A
(en)
|
1995-06-05 |
1998-05-26 |
The Trustees Of The University Of Pennsylvania |
Method for improved production of recombinant adeno-associated viruses for gene therapy
|
US6281010B1
(en)
|
1995-06-05 |
2001-08-28 |
The Trustees Of The University Of Pennsylvania |
Adenovirus gene therapy vehicle and cell line
|
US6506379B1
(en)
|
1995-06-07 |
2003-01-14 |
Ariad Gene Therapeutics, Inc. |
Intramuscular delivery of recombinant AAV
|
JP2001500015A
(ja)
|
1996-09-06 |
2001-01-09 |
トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
T7ポリメラーゼを利用する組換えアデノ随伴ウイルスの誘導可能な製造方法
|
AU4645697A
(en)
|
1996-09-11 |
1998-04-02 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Aav4 vector and uses thereof
|
KR100503701B1
(ko)
|
1996-11-20 |
2005-07-26 |
인트로겐 테라페티스, 인코퍼레이티드 |
아데노바이러스 벡터를 생산하고 정제하는 개선된 방법
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
US6566118B1
(en)
|
1997-09-05 |
2003-05-20 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
EP1015619A1
(en)
|
1997-09-19 |
2000-07-05 |
The Trustees Of The University Of Pennsylvania |
Methods and cell line useful for production of recombinant adeno-associated viruses
|
CA2303768C
(en)
|
1997-09-19 |
2009-11-24 |
The Trustees Of The University Of Pennsylvania |
Methods and vector constructs useful for production of recombinant aav
|
CA2324225A1
(en)
|
1998-03-20 |
1999-09-23 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
US6953690B1
(en)
|
1998-03-20 |
2005-10-11 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
US6984517B1
(en)
|
1998-05-28 |
2006-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector and uses thereof
|
US6491907B1
(en)
|
1998-11-10 |
2002-12-10 |
The University Of North Carolina At Chapel Hill |
Recombinant parvovirus vectors and method of making
|
FR2786478B1
(fr)
|
1998-11-30 |
2000-12-22 |
Commissariat Energie Atomique |
Confinement du cesium et/ou du rubidium dans des ceramiques apatitiques
|
JP4693244B2
(ja)
|
1999-03-18 |
2011-06-01 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
組換えアデノ随伴ウイルスのヘルパー無しの生産のための組成物および方法
|
US6258595B1
(en)
|
1999-03-18 |
2001-07-10 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
CA2375098A1
(en)
|
1999-06-02 |
2000-12-14 |
Trustees Of The University Of Pennsylvania |
Compositions and methods useful for production of recombinant viruses which require helper viruses
|
AU1071701A
(en)
|
1999-09-29 |
2001-04-30 |
Trustees Of The University Of Pennsylvania, The |
Methods for rapid peg-modification of viral vectors, compositions for enhanced gene transduction, compositions with enhanced physical stability, and uses therefor
|
US6365394B1
(en)
|
1999-09-29 |
2002-04-02 |
The Trustees Of The University Of Pennsylvania |
Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
|
EP1373527A1
(en)
|
2001-04-06 |
2004-01-02 |
CropDesign N.V. |
The use of double and opposite recombination sites for the single step cloning of two dna segments
|
EP1390490B1
(en)
|
2001-05-24 |
2009-04-15 |
Genzyme Corporation |
Muscle-specific expression vectors
|
ES2526341T3
(es)
|
2001-12-17 |
2015-01-09 |
The Trustees Of The University Of Pennsylvania |
Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas
|
US6845866B2
(en)
|
2002-10-10 |
2005-01-25 |
N. Henning Zieger |
Dispenser
|
US7605249B2
(en)
|
2002-11-26 |
2009-10-20 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
US8927269B2
(en)
|
2003-05-19 |
2015-01-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Avian adenoassociated virus and uses thereof
|
SI2277996T1
(sl)
|
2003-05-21 |
2014-12-31 |
Genzyme Corporation |
Postopki za izdelavo pripravkov rekombinantnih AAV virionov v bistvu brez praznih kapsid
|
ES2862206T3
(es)
|
2003-06-19 |
2021-10-07 |
Genzyme Corp |
Viriones de AAV con inmunorreactividad disminuida y sus usos
|
EP1636370B1
(en)
|
2003-06-20 |
2014-04-16 |
The Trustees of The University of Pennsylvania |
Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
|
US7291498B2
(en)
|
2003-06-20 |
2007-11-06 |
The Trustees Of The University Of Pennsylvania |
Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
US9233131B2
(en)
|
2003-06-30 |
2016-01-12 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
EP2298926A1
(en)
|
2003-09-30 |
2011-03-23 |
The Trustees of The University of Pennsylvania |
Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
|
WO2005056807A2
(en)
|
2003-12-04 |
2005-06-23 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health |
Bovine adeno-associated viral (baav) vector and uses thereof
|
WO2005072364A2
(en)
|
2004-01-27 |
2005-08-11 |
University Of Florida |
A modified baculovirus expression system for production of pseudotyped raav vector
|
EP1752536A4
(en)
|
2004-05-11 |
2008-04-16 |
Alphagen Co Ltd |
POLYNUCLEOTIDE CAUSING RNA INTERFERENCE AND METHOD OF REGULATING GENE EXPRESSION WITH THE USE OF THE SAME
|
US7427396B2
(en)
|
2004-06-03 |
2008-09-23 |
Genzyme Corporation |
AAV vectors for gene delivery to the lung
|
SI1945779T1
(sl)
|
2005-10-20 |
2013-07-31 |
Uniqure Ip B.V. |
Izboljĺ ani aav vektorji proizvedeni v celicah insekta
|
WO2007120542A2
(en)
|
2006-03-30 |
2007-10-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Aav capsid library and aav capsid proteins
|
US8945918B2
(en)
|
2006-08-24 |
2015-02-03 |
Virovek, Inc. |
Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor
|
US20100203083A1
(en)
|
2007-05-31 |
2010-08-12 |
Medigene Ag |
Mutated structural protein of a parvovirus
|
EP2019143A1
(en)
|
2007-07-23 |
2009-01-28 |
Genethon |
CNS gene delivery using peripheral administration of AAV vectors
|
EP2058401A1
(en)
|
2007-10-05 |
2009-05-13 |
Genethon |
Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
|
EP2312608B1
(en)
|
2008-07-09 |
2015-01-14 |
Kabushiki Kaisha Toshiba |
Target for x-ray tube, x-ray tube using the same, x-ray inspection system, and method for producing target for x-ray tube
|
DE102008060558B4
(de)
|
2008-12-04 |
2013-09-26 |
Eduard Buzetzki |
Verfahren zum katalytischen Cracken von Pflanzenölen und tierischen Fetten
|
EP2396343B1
(en)
|
2009-02-11 |
2017-05-17 |
The University of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
US8734809B2
(en)
|
2009-05-28 |
2014-05-27 |
University Of Massachusetts |
AAV's and uses thereof
|
US9163261B2
(en)
|
2010-02-22 |
2015-10-20 |
Koteswara Rao KOLLIPARA |
Adeno-associated virus 2/8—micro RNA-101 therapy for liver cancer
|
EP2547781A4
(en)
|
2010-03-17 |
2014-04-23 |
Anaptysbio Inc |
PROCESS FOR PRODUCING TRANSCRIPTION PRODUCTS USING CRYPTIC SPLICE SITES
|
CA3066596A1
(en)
|
2010-04-23 |
2011-10-27 |
University Of Massachusetts |
Cns targeting aav vectors and methods of use thereof
|
US10415056B2
(en)
|
2010-11-10 |
2019-09-17 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for generating adeno-associated viral vectors with undetectable capsid gene contamination
|
WO2012109570A1
(en)
|
2011-02-10 |
2012-08-16 |
The University Of North Carolina At Chapel Hill |
Viral vectors with modified transduction profiles and methods of making and using the same
|
KR20220056884A
(ko)
|
2011-04-22 |
2022-05-06 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
변이체 캡시드를 지니는 아데노-관련 바이러스 및 이의 사용 방법
|
US9169299B2
(en)
|
2011-08-24 |
2015-10-27 |
The Board Of Trustees Of The Leleand Stanford Junior University |
AAV capsid proteins for nucleic acid transfer
|
WO2013096955A1
(en)
|
2011-12-23 |
2013-06-27 |
Case Western Reserve University |
Targeted gene modification using hybrid recombinant adeno-associated virus
|
US9644205B2
(en)
|
2012-04-25 |
2017-05-09 |
The Regents Of The University Of California |
Synthetic promoter for modulating gene expression
|
CN111621507A
(zh)
|
2012-09-28 |
2020-09-04 |
北卡罗来纳-查佩尔山大学 |
靶向少突胶质细胞的aav载体
|
CN104937100B
(zh)
|
2012-12-25 |
2020-04-03 |
宝生物工程株式会社 |
Aav 变体
|
EP2954051B1
(en)
|
2013-02-08 |
2019-03-27 |
The Trustees Of The University Of Pennsylvania |
Modified aav8 capsid for gene transfer for retinal therapies
|
AU2014227766B2
(en)
|
2013-03-15 |
2018-10-04 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for dual glycan binding AAV vectors
|
ES2897508T3
(es)
|
2013-05-31 |
2022-03-01 |
Univ California |
Variantes de virus adenoasociados y métodos de uso de las mismas
|
ES2739288T3
(es)
|
2013-09-13 |
2020-01-30 |
California Inst Of Techn |
Recuperación selectiva
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
EP3134522B1
(en)
|
2014-04-25 |
2021-10-06 |
University of Massachusetts |
Recombinant aav vectors useful for reducing immunity against transgene products
|
US10746742B2
(en)
|
2014-04-25 |
2020-08-18 |
Oregon Health & Science University |
Methods of viral neutralizing antibody epitope mapping
|
MX2016014220A
(es)
|
2014-05-02 |
2017-02-06 |
Genzyme Corp |
Vectores de aav para la terapia genica de la retina y el snc.
|
WO2015191508A1
(en)
|
2014-06-09 |
2015-12-17 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
WO2016005001A1
(en)
|
2014-07-11 |
2016-01-14 |
Huawei Technologies Co., Ltd. |
Network device, user device and methods of access signal broadcast
|
ES2856090T3
(es)
|
2014-09-24 |
2021-09-27 |
Hope City |
Variantes de vectores de virus adenoasociados para la edición genómica de alta eficacia y sus métodos
|
RU2738421C2
(ru)
|
2014-10-21 |
2020-12-14 |
Юниверсити Оф Массачусетс |
Варианты рекомбинантных aav и их применения
|
US20180030096A1
(en)
|
2015-02-03 |
2018-02-01 |
University Of Florida Research Foundation, Inc. |
Recombinant aav1, aav5, and aav6 capsid mutants and uses thereof
|
US10472650B2
(en)
|
2015-02-20 |
2019-11-12 |
University Of Iowa Research Foundation |
Methods and compositions for treating genetic eye diseases
|
US10081659B2
(en)
|
2015-04-06 |
2018-09-25 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Adeno-associated vectors for enhanced transduction and reduced immunogenicity
|
EP3280451B8
(en)
|
2015-04-08 |
2019-09-25 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Viral gene therapy as treatment for cholesterol storage disease or disorder
|
US20180216133A1
(en)
|
2015-07-17 |
2018-08-02 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for achieving high levels of transduction in human liver cells
|
CA2996420A1
(en)
|
2015-09-28 |
2017-04-06 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for antibody-evading virus vectors
|
WO2017066764A2
(en)
|
2015-10-16 |
2017-04-20 |
William Marsh Rice University |
Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses
|
WO2017083722A1
(en)
|
2015-11-11 |
2017-05-18 |
Greenberg Kenneth P |
Crispr compositions and methods of using the same for gene therapy
|
US10240145B2
(en)
|
2015-11-25 |
2019-03-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
CRISPR/Cas-mediated genome editing to treat EGFR-mutant lung cancer
|
AU2016366549B2
(en)
|
2015-12-11 |
2022-11-10 |
California Institute Of Technology |
Targeting peptides for directing adeno-associated viruses (AAVs)
|
EP3417055B1
(en)
|
2016-02-16 |
2021-10-13 |
The Board of Trustees of the Leland Stanford Junior University |
Novel recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
|
WO2017151763A1
(en)
|
2016-03-01 |
2017-09-08 |
Intraop Medical Corporation |
Low energy electron beam radiation system that generates electron beams with precisely controlled and adjustable penetration depth useful for therapeutic applications
|
CN116286986A
(zh)
|
2016-07-29 |
2023-06-23 |
加利福尼亚大学董事会 |
具有变异衣壳的腺相关病毒病毒体和其使用方法
|
EP3500676A4
(en)
|
2016-08-16 |
2020-07-01 |
The University of North Carolina at Chapel Hill |
METHOD AND COMPOSITIONS FOR TARGETED GENE TRANSFER
|
US20200316221A1
(en)
|
2016-10-13 |
2020-10-08 |
University Of Massachusetts |
Aav capsid designs
|
EP3558393A4
(en)
|
2016-12-22 |
2020-11-11 |
Oregon Health & Science University |
ADENO-ASSOCIATED VIRAL VECTORS
|
BR112019025732A2
(pt)
*
|
2017-06-06 |
2020-06-30 |
University Of Massachusetts |
vetores de aav auto-reguladores para expressão segura de mecp2 na síndrome de rett
|
DK3645551T3
(da)
|
2017-06-27 |
2024-05-06 |
Regeneron Pharma |
Tropisme-modificerede rekombinante virusvektorer og anvendelser deraf til targetteret indføring af genetisk materiale i menneskeceller
|
WO2019006418A2
(en)
|
2017-06-30 |
2019-01-03 |
Intima Bioscience, Inc. |
ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY
|
EP3662060A2
(en)
|
2017-08-03 |
2020-06-10 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
RU2770922C2
(ru)
|
2017-09-20 |
2022-04-25 |
4Д Молекьюлар Терапьютикс Инк. |
Капсиды вариантов аденоассоциированных вирусов и методы их применения
|
WO2019068854A1
(en)
|
2017-10-06 |
2019-04-11 |
Ospedale San Raffaele S.R.L. |
GENE THERAPY OF NEURODEGENERATIVE DISEASES USING VAA VECTORS
|
US20200237799A1
(en)
|
2017-10-16 |
2020-07-30 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
JP7502991B2
(ja)
|
2017-10-16 |
2024-06-19 |
ボイジャー セラピューティクス インコーポレイテッド |
筋萎縮性側索硬化症(als)の治療
|
EP3759218A4
(en)
|
2018-02-28 |
2021-12-08 |
The University of North Carolina at Chapel Hill |
METHODS AND COMPOSITIONS FOR ANTIBODY AVOIDING VIRAL VECTORS
|
WO2019213668A1
(en)
|
2018-05-04 |
2019-11-07 |
Oregon Health & Science University |
Human anti-aav2 capsid polyclonal antibody epitopes
|
EP3793616A1
(en)
|
2018-05-15 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
WO2019222444A2
(en)
*
|
2018-05-16 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Directed evolution
|
WO2019222441A1
(en)
|
2018-05-16 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
EP3820885A4
(en)
*
|
2018-07-11 |
2022-04-20 |
The Brigham & Women's Hospital, Inc. |
METHODS AND COMPOSITIONS FOR ADMINISTRATION OF DRUGS ACROSS THE BLOOD-BRAIN BARRIER
|
EP3830107A2
(en)
|
2018-08-03 |
2021-06-09 |
Voyager Therapeutics, Inc. |
Aav variants with enhanced tropism
|
AU2019346447A1
(en)
|
2018-09-26 |
2021-04-29 |
California Institute Of Technology |
Adeno-associated virus compositions for targeted gene therapy
|
CA3115217A1
(en)
|
2018-10-02 |
2020-04-09 |
Voyager Therapeutics, Inc. |
Redirection of tropism of aav capsids
|
WO2020077165A1
(en)
|
2018-10-12 |
2020-04-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
AU2019401314A1
(en)
|
2018-12-21 |
2021-06-24 |
The Trustees Of The University Of Pennsylvania |
Compositions for DRG-specific reduction of transgene expression
|
EP3917945A4
(en)
|
2019-01-30 |
2023-02-08 |
The Broad Institute Inc. |
ADVANCED ADENO-ASSOCIATED VIRUS (AAVS) TARGETED DELIVERY SYSTEMS
|
CN113924115A
(zh)
|
2019-01-31 |
2022-01-11 |
俄勒冈健康与科学大学 |
用于aav衣壳的使用转录依赖性定向进化的方法
|
TW202102525A
(zh)
|
2019-03-21 |
2021-01-16 |
美商史崔德生物公司 |
重組腺相關病毒載體
|
EP3715358A1
(en)
|
2019-03-28 |
2020-09-30 |
Universität zu Köln |
Mutated adeno-associated virus capsid proteins, aav particle comprising the same and liver directed aav vector gene therapy
|
JP2022527199A
(ja)
|
2019-04-01 |
2022-05-31 |
テナヤ セラピューティクス, インコーポレイテッド |
操作されたカプシドを有するアデノ随伴ウイルス
|
TW202102526A
(zh)
|
2019-04-04 |
2021-01-16 |
美商銳進科斯生物股份有限公司 |
重組腺相關病毒及其用途
|
WO2020210655A1
(en)
|
2019-04-11 |
2020-10-15 |
California Institute Of Technology |
Virus compositions with enhanced specificity in the brain
|
TW202106699A
(zh)
|
2019-04-26 |
2021-02-16 |
美商愛德維仁生物科技公司 |
用於玻璃體內遞送之變異體aav蛋白殼
|
AU2020261435A1
(en)
|
2019-04-26 |
2021-11-25 |
Sangamo Therapeutics, Inc. |
Engineering AAV
|
WO2020223280A1
(en)
|
2019-04-29 |
2020-11-05 |
Voyager Therapeutics, Inc. |
Aav variants with enhanced tropism
|
WO2021025995A1
(en)
|
2019-08-02 |
2021-02-11 |
Voyager Therapeutics, Inc. |
Aav variants with enhanced tropism
|
EP4126910A1
(en)
|
2020-04-01 |
2023-02-08 |
Voyager Therapeutics, Inc. |
Redirection of tropism of aav capsids
|
WO2021216456A2
(en)
|
2020-04-20 |
2021-10-28 |
Tenaya Therapeutics, Inc. |
Adeno-associated virus with engineered capsid
|
EP4143305A2
(en)
|
2020-05-01 |
2023-03-08 |
The Broad Institute, Inc. |
Engineered central nervous system compositions
|
WO2021230987A1
(en)
|
2020-05-13 |
2021-11-18 |
Voyager Therapeutics, Inc. |
Redirection of tropism of aav capsids
|
WO2021242909A1
(en)
|
2020-05-26 |
2021-12-02 |
Shape Therapeutics Inc. |
High throughput engineering of functional aav capsids
|
CA3192600A1
(en)
|
2020-08-21 |
2022-02-24 |
Capsida, Inc. |
Adeno-associated virus compositions having preferred expression levels
|
WO2022076750A2
(en)
|
2020-10-07 |
2022-04-14 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns or muscle delivery
|
US20240141378A1
(en)
|
2021-03-03 |
2024-05-02 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
TW202334436A
(zh)
|
2021-11-02 |
2023-09-01 |
美商航海家醫療公司 |
Aav衣殼變異體及其用途
|
WO2023091948A1
(en)
|
2021-11-17 |
2023-05-25 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
WO2023092004A1
(en)
|
2021-11-17 |
2023-05-25 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|
WO2023091949A2
(en)
|
2021-11-17 |
2023-05-25 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
WO2023092002A2
(en)
|
2021-11-17 |
2023-05-25 |
Voyager Therapeutics, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis and disorders associatedwith the spinal cord
|
TW202346599A
(zh)
|
2022-02-08 |
2023-12-01 |
美商航海家醫療公司 |
Aav衣殼變異體及其用途
|